How Much Is Remdesivir Per Dose? | Price Facts Now

Buying a hospital-only medicine isn’t like grabbing a box from a pharmacy shelf. Remdesivir (brand: Veklury) is purchased by facilities, priced per 100-mg vial, and billed inside a larger hospital claim that can include preparation, supplies, nursing time, and pharmacy overhead. This guide breaks down the per-dose math that patients, caregivers, and bill reviewers ask about, and it shows how the number on a statement connects to the manufacturer’s list and the hospital’s posted charge.

Remdesivir Dose Cost At A Glance

Context	Unit	Typical Figure
Manufacturer list (commercial)	100-mg vial	$520 per vial
Government purchaser benchmark	5-day course	$2,340 total (≈$390/vial)
Day 1 in label regimen	200 mg (2 vials)	≈$1,040 at list, before facility add-ons
Maintenance day in label regimen	100 mg (1 vial)	≈$520 at list, before facility add-ons
Posted hospital “chargemaster” price	Per 100-mg	Ranges widely (≈$1,560 to >$5,000 in examples)

What A Single Remdesivir Dose Costs Today

Gilead’s published list for U.S. commercial buyers is $520 per 100-mg vial. The company also announced a government benchmark that worked out to about $390 a vial when purchased as a five-day course. A hospital then layers its own gross charge for the same vial, often several multiples of its acquisition price. That posted charge is a starting point for claims and contracting, not a guarantee of what anyone pays.

Real-world files help frame the spread. One posted chargemaster lists a premixed 100-mg entry around $1,560; another public spreadsheet shows a per-vial line above $5,000. Those sticker numbers are common in U.S. facility billing. The paid amount flows from the hospital’s contracts, payer rules, and whether the encounter is inpatient or outpatient. A private plan may settle near a negotiated rate far below the sticker. Public programs apply their own formulas.

How The Regimen Drives The Total

The FDA-approved inpatient regimen starts with 200 mg on day one, followed by 100 mg daily. Many patients receive a five-day course, so the pharmacy uses six vials in that common scenario. Translate that into list math and you land near $3,120 at commercial list or $2,340 under the government benchmark, before facility markups and before contract discounts.

Course Length And Dose Count

Courses can stop early if the patient is discharged or the care team changes direction. In that case, the vial count drops. Courses can also extend beyond five calendar days when clinically indicated, which adds one vial for each extra treatment day. The dose question here is simple: day one uses two vials; every treatment day after that uses one.

Outpatient Three-Day Use

In some settings, a three-day outpatient sequence (200 mg once, then 100 mg on days two and three) is used for select high-risk patients. That pattern uses four vials in total. The per-dose figure still points back to the same vial price and the same facility billing logic.

Why Hospital Bills Show Bigger Numbers

Hospitals maintain a public “chargemaster” that lists gross charges per item. That file feeds estimates, contracts, and claim edits. A pharmacy line on a statement often includes the vial, preparation time in the IV room, saline or diluent, tubing, and pharmacy handling. The bundle is one reason a medicine line can look steep next to the manufacturer’s list. The amount allowed after adjudication is what matters, and it’s usually far below the posted charge for insured patients.

Line Items Tied To A Dose

Beyond the vial, you may see IV supplies, infusion services, and monitoring on the same day. Those add to the bill but aren’t part of the vial’s list. The dose question touches all of these because the order triggers the prep and the associated work inside the pharmacy cleanroom. If you want a clean view, ask for the itemized bill and look for the pharmacy revenue code lines alongside the room and respiratory entries.

Where Official Benchmarks Come From

The numbers above trace back to two anchors. First, Gilead’s pricing FAQ laid out the U.S. list of $520 per 100-mg vial and a government benchmark that equals $2,340 for a five-day course. Second, Medicare created a temporary inpatient add-on during the emergency period to blunt new drug costs; details sit on CMS’s page for the new COVID-19 treatments add-on (NCTAP), which sunset on September 30, 2023. These aren’t guarantees of what any person pays, yet they explain why a plan’s allowed amount can differ from a hospital’s pharmacy sticker.

What Patients Usually Pay

Because this is an infusion inside a facility, patients don’t “buy” a vial at a retail counter. The charge lives on the hospital claim. Out-of-pocket depends on benefit design, network status, and the claim type. Many commercial plans apply the medical benefit with deductible and coinsurance until the yearly max. Public programs process under their set payment rules. Uninsured patients can qualify for hospital financial assistance or prompt-pay discounts based on income and residence.

Ways To Steer Your Costs

• Request the itemized bill. It separates pharmacy, infusion, supplies, labs, and room so you can see how the medication was recorded.
• Read the explanation of benefits. It shows the plan’s allowed amount versus the hospital’s gross charge and flags any denials or partial payments.
• Call patient financial services. Ask which line was the drug, which lines were administration, and whether charity screening or payment plans fit your situation.

Dose Cost Versus Course Cost

Searchers ask for a “per dose” figure, yet the actual spend depends on the total days ordered and the place of care. Day one uses two vials, so it’s the priciest single day at the list level. Every extra day adds exactly one vial. A three-day sequence uses four vials; a five-day course uses six. Then the facility’s charge and the payer’s contract push the final number up or down from the raw list.

Quick Math Examples

• One treatment day (200 mg): two vials at list ≈ $1,040 before facility charges.
• Three treatment days (200 mg + 100 mg + 100 mg): four vials at list ≈ $2,080 before facility charges.
• Five treatment days: six vials at list ≈ $3,120 before facility charges; under the government benchmark, ≈ $2,340 for the same six vials.

How Insurance Mechanics Shape The Final Bill

For in-network care, the plan and hospital follow their contract. The payer applies its rate schedule, which can bundle pharmacy into a case-rate for an inpatient stay or pay line by line in outpatient settings. For out-of-network hospitals, an allowed amount may be tied to a percent of a usual-and-customary benchmark or a statutory schedule, and the balance can be billable unless protections apply. If a bill seems off, ask the plan to check units and revenue codes on the pharmacy line; unit errors happen.

Appeals And Audits That Help

If your explanation of benefits shows a denial or a partial allowance tied to code mismatch, request a corrected claim. If the hospital billed more dose units than administered, ask for a pharmacy log to verify. If an infusion service was billed twice for the same time window, request a review. These steps don’t debate whether the medicine was used; they simply square the bill with the chart.

International Pricing Notes

Gilead entered voluntary licenses with multiple manufacturers to supply many lower-income markets. Those suppliers set their own prices inside tender systems, so the per-dose figure abroad can be far below the U.S. list. In higher-income systems that buy the originator, the health ministry or hospital group often negotiates acquisition terms and then pairs that with a fixed payment scheme for hospitals. The math still follows the same path: one vial per maintenance day, two vials on the first day.

Evidence Behind The Spend

Economic evaluations during the pandemic looked at course costs across a wide span, from low manufacturing estimates in global models to branded list levels used in U.S. budgets. Small shifts in key inputs—length of stay reduction, admission rates, or mortality assumptions—move those results. For patients and families, the practical takeaway is simpler: the invoice reflects both the vial’s price and the value placed on hospital capacity at that time and place.

When A Posted Charge Looks Out Of Range

It’s common to see a large gross price for a single vial on a statement. After adjudication, the allowed amount can drop sharply. If the allowed number still looks odd, ask for a line-by-line audit. Errors crop up in long claims: duplicate lines, mis-keyed units, or an incorrect revenue code can inflate a day’s total. If a correction is needed, hospitals can adjust the claim and the payer can reprocess the explanation of benefits.

Reading Your Paperwork Like A Pro

On The Itemized Bill

Look for a pharmacy revenue code line. You should see a description that matches the strength (100 mg) and the route (IV). If day one shows a dose count of “2,” that’s normal. Each later treatment day should show “1.” If you see extra units on a day without an order, ask for a review.

On The Explanation Of Benefits

Find three numbers: the gross charge, the allowed amount, and your responsibility. The gap between the first two tells you how strong the discount was. If the allowed amount exceeds the plan’s schedule, ask for the page of the contract or fee schedule the agent is using so you can cross-check.

Patient Pathways To Lower Liability

Payer Type	What’s Typically Paid	Common Patient Liability
Commercial plan	Negotiated rate below gross hospital charge	Deductible and coinsurance until out-of-pocket max
Medicare inpatient	DRG payment; emergency add-on ended 9/30/2023	Part A deductible, then coinsurance by length of stay
Medicaid	Program-set payment, often below gross charge	Usually minimal, per state rules
Uninsured	Hospital policy discount or charity care when eligible	Income-based discounts; payment plans available

Key Takeaways For A Per-Dose Answer

At the list level, think in units of $520 per 100-mg vial for U.S. commercial buyers. Day one uses two units. Each later treatment day uses one. Hospitals post much larger gross charges for that same vial, and payers don’t usually pay the sticker. The number that lands on a statement reflects acquisition benchmarks, facility markups, and contracts—plus the simple count of how many days were ordered.

Method And Sources

This guide uses the manufacturer’s pricing FAQ, which set the per-vial U.S. list and the government benchmark for a five-day course, and CMS’s summary of the temporary inpatient add-on that applied during the public health emergency. Those two anchors explain where the per-dose math comes from and why the final allowed amount on a bill can diverge from a hospital’s pharmacy sticker.